Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 3.30
Ask: 4.80
Change: 0.19 (4.92%)
Spread: 1.50 (45.455%)
Open: 3.86
High: 0.00
Low: 0.00
Prev. Close: 3.86
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Issuance of Patent

13 Dec 2006 14:07

PROTEOME SCIENCES plc

PRESS RELEASE

Issuance of TMT‚® Patent in Canada

13th December 2006. Proteome Sciences plc is pleased to announce that it has today received the official Letters Patent for Canadian Patent Number 2,460,131 entitled "Mass Markers" which was granted on November 21st 2006. The claims of the issued patent relate to specific isobaric mass tag structures which represent one class of Proteome Sciences Tandem Mass Tag‚® (TMT‚®) technology. The patent term is 20 years from 16th September 2002.

There are currently two international patent applications relating to TMT. Canadian Patent Number 2,460,131 was the second TMT‚® patent (TMT2) to be filed and claims isobaric mass tags with peptide structures and various methods of their use. The earlier TMT‚® patent (TMT1) is in process of prosecution at the Canadian Intellectual Property Office.

Commenting on the issuance Christopher Pearce, Chief Executive of Proteome Sciences said:

"Recent events, including the launch of isobaric mass tags by Perkin Elmer (ExacTags) and new applications for the isobaric iTRAQ mass tags by Applied Biosystems highlight the growing recognition of the importance of these reagents across life sciences research. We have been working on the development of a number of TMT functions to enhance our own biomarker discovery, validation and measurement efforts and to improve the ProteoSHOP‚® offering to our customers with particular emphasis on supporting applications in pre-clinical pharmaceutical discovery and clinical trials of new drugs.

The issuance of one of the TMT‚® family of patents in Canada is another significant milestone in the company's development. It validates the patentability of the TMT‚® isobaric mass tags in a sizeable economic market and underpins the value of our pending TMT1 and TMT2 applications in other territories.

This has increased the profile and economic value of our isobaric mass tags and will be incorporated into the TMT‚® licence negotiations.

We anticipate that issuance of the first Canadian patent relating to the TMT‚® technology will shortly be followed by further progress with both TMT1 and TMT2 applications in other territories."

EndsNotes to editors:Proteome Sciences plc

Proteome Sciences, a global leader in applied proteomics, uses high sensitivity proprietary technologies to detect differentially expressed proteins in diseases. The protein biomarkers discovered in body fluids or tissues are validated, developed and commercialised as diagnostic, prognostic or therapeutic products through strategic alliances and out-licensing.

Through its unique ProteoSHOP‚® toolbox, Proteome Sciences provides high sensitivity/high throughput proteomics solutions, including traditional two dimensional gel-based electrophoresis (2DE) and proprietary gel-free protein sequence tag technologies (PST‚®, qPST¢â€ž¢& TMT‚®), to major pharma, biotechnology and diagnostic companies, to discover and exploit protein biomarkers. Sensitizer‚® chemical mass tags have been developed separately as a series of stand-alone reagents.

For further information please visit www.proteomics.com .

Enquiries:

Proteome Sciences plc

Dr. Ian Pike, Business Development Director

Email: ian.pike@proteomics.com

Christopher Pearce, Chief Executive Officer

Email: christopher.pearce@proteomics.com

Tel: +44 (0)1932 865065

Public Relations for Proteome Sciences

IKON AssociatesAdrian ShawTel: +44 (0)1483 535102Mobile: +44 (0)797 9900733

Email: adrian@ikonassociates.com

PROTEOME SCIENCES PLC
Date   Source Headline
18th Apr 20078:30 amPRNService Agreement with Onconome Inc.
13th Apr 200712:20 pmPRNNotifiable Interest
13th Apr 200712:13 pmPRNNotifiable Interest
21st Mar 20077:00 amPRNHolding(s) in Company
21st Mar 20077:00 amPRNHolding(s) in Company
21st Mar 20077:00 amPRNHolding(s) in Company
21st Feb 20079:41 amPRNPress Release
19th Feb 20074:40 pmPRNHolding(s) in Company
15th Jan 20077:00 amPRNStatement re Issuance of Patent
5th Jan 200712:29 pmPRNHolding(s) in Company
21st Dec 20064:59 pmPRNHolding(s) in Company
18th Dec 20062:12 pmPRNStatement re: Patent
13th Dec 20062:07 pmPRNStatement re Issuance of Patent
13th Dec 200611:32 amPRNTotal Voting Rights
11th Dec 200610:49 amPRNStatement re: Issuance of Patent
31st Oct 200612:42 pmPRNHolding(s) in Company
30th Oct 20065:38 pmPRNBlocklisting
5th Sep 20069:54 amPRNDirectorate Change
27th Jul 20061:53 pmPRNHolding(s) in Company
27th Jul 200612:04 pmPRNResult of AGM
18th Jul 20067:00 amPRNAppointment
17th Jul 20064:41 pmRNSSecond Price Monitoring Extn
17th Jul 20064:36 pmRNSPrice Monitoring Extension
6th Jul 20065:12 pmPRNHolding(s) in Company
4th Jul 20064:42 pmRNSSecond Price Monitoring Extn
4th Jul 20064:36 pmRNSPrice Monitoring Extension
29th Jun 20062:00 pmPRNFinal Results
28th Jun 20064:42 pmRNSSecond Price Monitoring Extn
28th Jun 20064:36 pmRNSPrice Monitoring Extension
28th Jun 20064:32 pmPRNRe Licence Agreement
23rd May 20063:08 pmPRNRe Licence Agreement
26th Apr 20062:52 pmPRNBlocklisting
20th Apr 20064:39 pmPRNHolding(s) in Company
20th Apr 20064:36 pmPRNHolding(s) in Company
7th Apr 20065:20 pmRNSNotifiable Interest
22nd Mar 20064:00 pmPRNNotifiable Interest
22nd Feb 20062:30 pmRNSNotifiable Interest
13th Feb 20065:21 pmRNSNotifiable Interest Corrected
13th Feb 20065:18 pmRNSNotifiable Interest
10th Feb 20064:26 pmRNSNotifiable Interest
9th Feb 20068:30 amRNSNotifiable Interest
24th Jan 20064:32 pmRNSNotifiable Interest
25th Oct 20059:51 amPRNBlocklisting
26th Sep 200510:37 amPRNNotice of Results
5th Sep 20051:55 pmPRNHolding(s) in Company
23rd Jun 200511:18 amPRNHolding(s) in Company
20th Jun 200512:39 pmPRNHolding(s) in Company
16th Jun 20053:18 pmPRNHolding(s) in Company
7th Jun 20058:43 amPRNStatement re Grant of Options
3rd Jun 20053:32 pmPRNCorrection : Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.